CANNABIS GLOBAL, INC. (CBGL) Financial Statements (2025 and earlier)

Company Profile

Business Address 520 S. GRAND AVENUE
LOS ANGELES, CA 90071
State of Incorp. NV
Fiscal Year End August 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

5/31/2022
MRQ
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 30,8132,338152,0824,6524,8325,012
Cash and cash equivalents 30,8132,338152,0824,6524,8325,012
Receivables 154,379     
Inventory, net of allowances, customer advances and progress billings 189,08175,3382,299   
Inventory 189,08175,3382,299   
Other current assets 7,992     
Other undisclosed current assets 59,800     
Total current assets: 442,06577,676154,3814,6524,8325,012
Noncurrent Assets
Operating lease, right-of-use asset 634,637  
Property, plant and equipment 218,53525,40613,248   
Long-term investments and receivables 650,0001,714,90340,000   
Due from related parties   40,000   
Long-term investments 650,0001,714,903    
Intangible assets, net (including goodwill) 9,342,967     
Goodwill 8,842,967     
Intangible assets, net (excluding goodwill) 500,000     
Deposits noncurrent assets   7,200   
Other undisclosed noncurrent assets 50,600507,200    
Total noncurrent assets: 10,896,7392,247,50960,448   
TOTAL ASSETS: 11,338,8042,325,185214,8294,6524,8325,012
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 943,027266,86998,69139,99423,89315,643
Interest and dividends payable 212,20233,301 28,30621,30714,308
Accounts payable 730,825233,56892,80611,6882,5861,335
Accrued liabilities   5,885   
Debt 1,383,6501,866,87233,33470,00070,00070,000
Derivative instruments and hedges, liabilities 4,747,6141,125,803    
Due to related parties 110,6781,1391,1396,200  
Other undisclosed current liabilities 1,562,237499,78820,25023,411  
Total current liabilities: 8,747,2063,760,471153,414139,60593,89385,643
Noncurrent Liabilities
Long-term debt and lease obligation 1,235,791     
Long-term debt, excluding current maturities 672,794     
Operating lease, liability 562,997  
Other undisclosed noncurrent liabilities (562,997)     
Total noncurrent liabilities: 1,235,791     
Total liabilities: 9,982,9973,760,471153,414139,60593,89385,643
Equity
Equity, attributable to parent, including: (2,212,343)(1,435,286)61,415(134,953)(89,061)(80,631)
Preferred stock 600600    
Common stock 84,9382,7081,25318,3865,3865,386
Additional paid in capital 11,591,8294,618,1681,184,923584,665556,711556,711
Accumulated deficit (13,891,788)(6,056,949)(1,127,601)(738,004)(651,158)(642,728)
Other undisclosed equity, attributable to parent 2,0781872,840   
Equity, attributable to noncontrolling interest 3,568,150     
Total equity: 1,355,807(1,435,286)61,415(134,953)(89,061)(80,631)
TOTAL LIABILITIES AND EQUITY: 11,338,8042,325,185214,8294,6524,8325,012

Income Statement (P&L) (USD)

5/31/2022
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Revenues 1,601,03727,004100   
Gain on disposition of assets for financial service operations 2,022,060   
Other income 1,642 100   
Cost of revenue (1,416,779)(24,521)    
Gross profit: 184,2582,483100   
Operating expenses (2,128,182)(3,626,375)(549,918)(51,036)(1,431)(1,558)
Other undisclosed operating loss   (100)   
Operating loss: (1,943,924)(3,623,892)(549,918)(51,036)(1,431)(1,558)
Nonoperating income (expense) (6,172,058)(1,305,456)160,321   
Interest and debt expense (7,437,340)(1,311,201)168,048(35,810)(6,999)(6,267)
Loss from continuing operations before equity method investments, income taxes: (15,553,322)(6,240,549)(221,549)(86,846)(8,430)(7,825)
Loss from equity method investments (211,376)     
Loss from continuing operations: (15,764,698)(6,240,549)(221,549)(86,846)(8,430)(7,825)
Loss before gain (loss) on sale of properties:(15,764,698)(6,240,549)(221,549)(86,846)(8,430)(7,825)
Other undisclosed net income 7,648,7161,311,201    
Net loss: (8,115,982)(4,929,348)(221,549)(86,846)(8,430)(7,825)
Net income attributable to noncontrolling interest 281,143     
Other undisclosed net loss attributable to parent   (168,048)   
Net loss available to common stockholders, diluted: (7,834,839)(4,929,348)(389,597)(86,846)(8,430)(7,825)

Comprehensive Income (USD)

5/31/2022
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Net loss: (8,115,982)(4,929,348)(221,549)(86,846)(8,430)(7,825)
Comprehensive loss: (8,115,982)(4,929,348)(221,549)(86,846)(8,430)(7,825)
Comprehensive income, net of tax, attributable to noncontrolling interest 281,143     
Comprehensive loss, net of tax, attributable to parent: (7,834,839)(4,929,348)(221,549)(86,846)(8,430)(7,825)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: